Thus, to confirm our data and further evaluate the impact of MTA on intra-tumoral immune cell crosstalk, additional studies in MTAP-deficient tumor mouse models or ex vivo analyses of tumor tissues of different cancer entities are needed. The gene discussed is MTAP; the disease is cancer.